NANDROLONE DECANOATE Drug Patent Profile
✉ Email this page to a colleague
When do Nandrolone Decanoate patents expire, and when can generic versions of Nandrolone Decanoate launch?
Nandrolone Decanoate is a drug marketed by Abraxis Pharm, Am Regent, Epic Pharma Llc, and Watson Labs. and is included in ten NDAs.
The generic ingredient in NANDROLONE DECANOATE is nandrolone decanoate. There are fifteen drug master file entries for this compound. Additional details are available on the nandrolone decanoate profile page.
Summary for NANDROLONE DECANOATE
US Patents: | 0 |
Applicants: | 4 |
NDAs: | 10 |
Raw Ingredient (Bulk) Api Vendors: | 61 |
Clinical Trials: | 10 |
Patent Applications: | 1,434 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NANDROLONE DECANOATE at DailyMed |
Recent Clinical Trials for NANDROLONE DECANOATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
King Edward Medical University | N/A |
Morten Tange Kristensen PT, PhD | Phase 2 |
University Hospital Ostrava | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for NANDROLONE DECANOATE
US Patents and Regulatory Information for NANDROLONE DECANOATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abraxis Pharm | NANDROLONE DECANOATE | nandrolone decanoate | INJECTABLE;INJECTION | 088290-001 | Oct 3, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | NANDROLONE DECANOATE | nandrolone decanoate | INJECTABLE;INJECTION | 088554-001 | Feb 10, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Epic Pharma Llc | NANDROLONE DECANOATE | nandrolone decanoate | INJECTABLE;INJECTION | 087519-001 | Sep 28, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | NANDROLONE DECANOATE | nandrolone decanoate | INJECTABLE;INJECTION | 086598-001 | Jan 13, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |